Indeed, in metastasis models the STAT3 signaling pathway has been shown to mediate LRG1-driven tumor metastasis, and that this can be significantly reduced in Lrg1 deficient mice or following LRG1 antibody blockade (28, 29, 31). The gene discussed is STAT3; the disease is neoplasm.